Celsius Therapeutics is a company that uses single-cell RNA sequencing and genomic analysis to develop treatments for immuno-inflammatory diseases. It focuses on the development of an antibody program for inflammatory bowel disease by analyzing human tissue samples and identifying a myeloid target.